Important note
This AI stock analysis for Shattuck Labs is not up to date. Creating and accessing our AI stock Analysis (powered by our data and Chat GPT) is only available for our premium users. Sign up to get access today!
Shattuck Labs - AI Stock Analysis
Analysis generated October 4, 2024
Shattuck Labs is a biopharmaceutical company focused on developing therapies that leverage their proprietary Agonist Redirected Checkpoint (ARC) platform. With a core focus on innovative treatment strategies, Shattuck Labs aims to address unmet needs in oncology and autoimmune disease markets. As a relatively new entrant in the biotechnology space, the company's potential for growth is largely dependent on the success of its clinical trials and the ability to commercialize its pipeline products.
Fundamental Analysis
For the last quarter, Shattuck Labs reported a revenue of $1.6M. This figure represents an astonishing increase of 44.30% compared to the previous quarter, and a 704.50% increase compared to the same quarter last year. This significant year-over-year growth in revenue is a positive indicator of the company's expanding market reach and product acceptance.
The net income for the last quarter was -$22M, representing a decrease of 16.47% compared to the previous quarter. Although this might be a point of concern, it's important to note that the year-over-year decrease is only 0.97%, suggesting stabilization. Such figures indicate that while the company is still facing losses, it is working towards financial stability.
The EBITDA for the last quarter was $0, showcasing a 100.00% improvement from the previous quarter. This suggests that the company has managed to maintain its operating profitability, which is a healthy signal for future growth.
Technical Analysis
Shattuck Labs’ current stock price is $1.24, indicating a sharp decrease of 65.27% when compared to a month ago. This could be alarming for short-term investors. When compared to one year ago, the stock price has decreased by 11.43%, suggesting sustained bearish trend. The current trend is bearish, as indicated by the SMA10 of 2.81 being lower than the previous SMA10 of 3.06. The RSI is at 50, indicating a neutral condition, which doesn't signal overbought or oversold conditions at present but neither does it provide confidence for significant immediate upward movement.
Alternative Data Analysis
Looking at Shattuck Labs' job postings and employee sentiment, the company currently has 2 open positions which has remained stable over the last few months. This signals sound operational stability. Furthermore, estimated monthly visits to Shattuck Labs’ webpage stand at 6,000, reflecting a 20% increase over the last few months. This upward trend can be perceived as a potential indicator of rising customer interest and possible market expansion.
According to AltIndex's predictive AI score, Shattuck Labs has scored 76. In the context of this analysis, a score of 76 suggests a strong "buy" signal, implying that, based on all fundamental, technical, and alternative data, Shattuck Labs is currently undervalued and holds promise for future investment.
Conclusion and Recommendation
Based on the above comprehensive analysis, Shattuck Labs shows a mixed yet promising prospect. The fundamental analysis highlights significant revenue growth despite current net income losses, while the technical analysis flags some bearish trends and short-term concerns. However, the alternative data signals stable operational performance and increasing customer engagement, providing a positive outlook for long-term prospects. Coupled with an encouraging AI score of 76, it is recommended that investors consider Shattuck Labs as a potential buy, especially those focusing on long-term growth and willing to handle short-term volatility.
Disclaimer: This AI stock analysis, generated by an experimental AI tool, is for informational purposes only and not financial advice. Information is based on publicly available data and may not always be accurate or current.
